A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population Paulo R. ShiromaMario Renato Velit-SalazarYelena Vorobyov Systematic Review 07 June 2022 Pages: 549 - 566
Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction Michele CorrealePietro MazzeoNatale Daniele Brunetti Review Article 20 June 2022 Pages: 567 - 579
Guillain–Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data Marina AtzenhofferMarine AuffretThierry Vial Original Research Article 09 June 2022 Pages: 581 - 592
Thromboembolic Events While Taking Direct Oral Anticoagulants: An Analysis of Post-market WHO Database Reports from 2012 to 2020 Darko MitrovicWouter EmmensPatricia van den Bemt Original Research Article 08 June 2022 Pages: 593 - 598
Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan Xiuting MoKensuke MoriwakiKojiro Shimozuma Original Research Article 08 June 2022 Pages: 599 - 609
Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell Carcinoma Daniel M. GeynismanMauricio BurottoBradley McGregor Original Research Article Open access 13 June 2022 Pages: 611 - 622
Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects Qi ShenYing JinZhenlei Wang Original Research Article 21 June 2022 Pages: 623 - 630